highly significantP < 0.01
Oral administration of MEFJ for 21 days exhibited highly significant ( P < 0.01) hypoglycemic activity and also correction of altered biochemical parameters, namely cholesterol and triglycerides significantly ( P < 0.05).
Oral administration of MEFJ for 21 days exhibited highly significant ( P < 0.01) hypoglycemic activity and also correction of altered biochemical parameters, namely cholesterol and triglycerides significantly ( P < 0.05).